BVS News and Press, Bioventus Inc. From 04/08/22

DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that TheraSkin coverage now includes three out of the four largest commercial plan...

DURHAM, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on April 4, 2022 of previously disclosed inducement equity awards to ...

Shares of Bioventus (NASDAQ: BVS) were sinking 11% as of 10:46 a.m. ET on Monday. The decline came after the company announced that it exercised a call option to acquire CartiHeal. Bioventus previously made a $15 million equity investment in CartiHeal in 2020 and acquired an option ...

Medical device maker, Bioventus (BVS -12.9%) announced on Monday that it exercised a call option to acquire privately-held CartiHeal for nearly $315 million, excluding its current ownership interest. The transaction expected close in 2Q 2022 also includes an additional payment of approximatel...

Gainers: Protalix BioTherapeutics (PLX) +70%. Biophytis (BPTS) +21%. Clovis Oncology (CLVS) +13%. IN8bio (INAB) +13%. Acer Therapeutics (ACER) +12%. Losers: Curis (CRIS) -39%. Longeveron (LGVN) -15%. Bioventus (BVS) -14%. Clever Leaves (CLVR) -8%. NanoV...

DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has exercised its call option to acquire CartiHeal Ltd., excluding the own...

Bioventus has seen rapid growth in 2021, mostly induced by dealmaking. The company has been hyperactive on the dealmaking front, which creates many moving parts into 2022. Investors are not convinced that real value is created here, yet the set-up is starting to look a bit more co...

DURHAM, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will participate in a fireside chat at the Canaccord Genuity Musculoskeletal Conference on Tuesday, ...

The following slide deck was published by Bioventus Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Bioventus Inc. 2021 Q4 - Results - Earnings Call Presentation

Image source: The Motley Fool. Bioventus Inc. (NASDAQ: BVS) Q4 2021 Earnings Call Mar 10, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Bioventus Inc. (BVS) Q4 2021 Earnings Call Transcript